期刊文献+

隔姜灸联合穴位贴敷治疗妊娠剧吐疗效观察 被引量:2

Observation of the curative effect of ginger moxibustion and acupoint application in the treatment of pregnancy hyperemesis
下载PDF
导出
摘要 目的探究分析隔姜灸联合穴位贴敷治疗妊娠剧吐的临床疗效。方法选取40例妊娠剧吐孕产妇,根据随机数字表法将其分为对照组与研究组,各20例。对照组采用常规护理,研究组在对照组基础上联合隔姜灸与穴位贴敷干预。比较两组孕产妇干预效果、干预前后中医证候积分,另利用妊娠恶心呕吐专用量表(PUQE)与妊娠恶心呕吐生活质量量表(NVPQOL)判定孕产妇干预前后剧吐严重程度与生活质量。结果研究组孕产妇干预总有效率高于对照组,差异具有统计学意义(P<0.05)。干预前,两组各中医证候积分比较,差异无统计学意义(P>0.05);干预后,两组各中医证候积分低于干预前,且研究组孕产妇恶心、呕吐、饮食障碍中医症后积分为(0.45±0.18)、(0.67±0.21)、(0.55±0.23)分,明显低于对照组的(1.15±0.26)、(1.32±0.33)、(1.26±0.29)分,差异具有统计学意义(P<0.05)。干预前,两组PUQE、NVPQOL评分比较,差异无统计学意义(P>0.05);干预后,两组PUQE、NVPQOL评分低于干预前,且研究组明显低于对照组,差异具有统计学意义(P<0.05)。结论对于妊娠剧吐孕产妇,临床采取隔姜灸联合穴位贴敷干预的疗效可靠,能够显著减轻孕产妇的恶心呕吐症状,改善饮食障碍情况,继而提升其预后生活质量,值得推广。 Objective To explore and analyze the clinical effect of ginger moxibustion combined with acupoint application on hyperemesis gravidarum. Methods 40 pregnant women with hyperemesis gravidarum were selected and divided into control group and study group with 20 cases each according to random number table method. The control group received routine nursing, and the study group combined ginger moxibustion and acupoint application on the basis of the control group. The effects of intervention and TCM syndrome scores before and after intervention were compared between the two groups, and the severity and quality of life of hyperemesis before and after intervention were determined using the Special Scale for Pregnancy nausea and Vomiting(PUQE) and Quality of Life Scale for Pregnancy nausea and vomiting(NVPQOL).Results The total effective rate of intervention in the study group was higher than that in the control group, the difference was statistically significant(P<0.05). Before intervention, there was no significant difference in TCM syndrome scores between the two groups(P>0.05). After intervention, the scores of TCM syndrome in the two groups were lower than before intervention, and the scores of TCM symptoms after nausea, vomiting and eating disorders in the study group were(0.45±0.18),(0.67±0.21) and(0.55±0.23).Significantly lower than the control group(1.15±0.26),(1.32±0.33),(1.26±0.29), the difference was statistically significant(P<0.05). Before intervention, there was no significant difference in PUQE and NVPQOL scores between the two groups(P>0.05). After intervention, PUQE and NVPQOL scores of the two groups were lower than before intervention, and the study group was significantly lower than the control group, the difference was statistically significant(P<0.05). Conclusion For pregnant women, the clinical effect of ginger moxibustion and acupuncture point application intervention is reliable, which can significantly reduce the nausea and vomiting symptoms, improve the dietary disorders, and then improve their prognosis and quality of life, which is worth promoting.
作者 聂义茹 Nie Yiru(Department of Gynecology,Lianyungang Maternal and Child Health Care Hospital,Lianyungang 222000,China)
出处 《实用妇科内分泌电子杂志》 2022年第20期14-16,共3页 Electronic Journal of Practical Gynecological Endocrinology
关键词 妊娠剧吐 隔姜灸 穴位贴敷 疗效观察 生活质量 Hyperemesis Ginger moxibustion Acupoint application Efficacy observation Quality of life
  • 相关文献

二级参考文献83

  • 1王娟.穴位贴敷联合耳穴埋豆治疗妊娠剧吐的临床疗效分析[J].医学信息,2017,30(5):188-189. 被引量:6
  • 2American College of Obstetrics and Gynecology. ACOG Practice Bulletin: nausea and vomiting of pregnancy[J]. Obstet Gynecol,2015,126 ( 3 ) : e 12-e24.
  • 3Niebyl JR. C|inical practice. Nausea and vomiting in pregnancy[J]. N Engl J Med, 2010, 363(16): 1544-1550.
  • 4Goodwin TM. Hyperemesis gravidarum[J]. Obstet Gyneeol Clin North Am, 2008, 35(3):401-417.
  • 5Tamay AG, Ku~qu NK. Hyperemesis gravidarum: Current aspect[J]. J Obstet Gyneeol, 2011, 31 (8):708-712.
  • 6Bottomley C, Bourne T. Management strategies for hyperemesis[J]. Best Praet lles Cliu Obstet Gynaecol, 2009, 23(4):549-564.
  • 7Di Gangi S, Gizzo S, Patrelli TS, et al. Wernieke' s eneephalopathy complicating hyperemesis gravidarum: from the background to the present[J]. J Maternal FetalNeonatal Med, 2012, 25(8):1499-1504.
  • 8Slaughter SR, Hearns-Stokes R, van der Vluqt T, et al. FDA approval of doxylamine-pyridoxine therapy for use in pregnancy[J]. N Engl J Med, 2014,307(12): 1081-1083.
  • 9Berkovitch M, Elbirt D, Addis A, et al. Fetal effects of metoelopramide therapy for nausea and vomiting of pregnancy [J]. N Engl J Med, 2000, 343(6):445-446.
  • 10Matok I, Gorodischer R, Koren G, et al. The safety of metoclopramide use in the first trimester of pregnancy[J]. N Engl J Med, 2009, 360(24):2528-2535.

共引文献185

同被引文献34

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部